Barrow, Hanley, Mewhinney & Strauss’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.31K Buy
+57
New +$5.05K ﹤0.01% 268
2025
Q3
Sell
-44
Closed -$3.07K 350
2025
Q2
$3.07K Buy
+44
New +$2.51K ﹤0.01% 283

Other funds holding ACLS

Barrow, Hanley, Mewhinney & Strauss's ACLS Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss opened a new position in Axcelis (ACLS) in Q1 2026: 57 shares worth $5.31K. The stake represents ﹤0.01% of the portfolio and ranks #268 among its holdings. This is a return to the name: Barrow, Hanley, Mewhinney & Strauss previously reported a position in ACLS as recently as Q2 2025.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ACLS in Q2 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 57 shares of Axcelis worth $5.31K as of Q1 2026.
  • Axcelis was a new Barrow, Hanley, Mewhinney & Strauss position in Q1 2026.
  • Axcelis made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #268 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Axcelis in Q2 2025 and has held it in 2 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.